Cardinal Health, Inc. CAH
267.82 USD +5.89 (+2.25%)
At closeNov 5, 2026, 7:36 PM EST
267.71 -0.11 -0.04%
After hours · Nov 5, 7:36 PM ET
267.61 Day range 286.29
180.45 52-week range 286.29
- YTD
- +30.33%
- 1 year
- +36.09%
Analyst view
Consensus: buy
Buy
Price target (mean) 274.87 +2.6% upside
Now 267.82
- Target (low)
- 235.00
- Target (mean)
- 274.87
- Target (high)
- 295.00
Ratings (0m) 17 14 buy · 3 hold · 0 sell
- Strong buy3
- Buy11
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 17
- 1 month ago 17
- 2 months ago 18
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 3.13 | 3.07 – 3.37 | 2.63 | +19.0% | 68.29B | +4.0% | 13 |
| Next quarter | 3.36 | 2.82 – 3.55 | 3.17 | +6.1% | 63.85B | +4.8% | 13 |
| Current year | 12.56 | 12.51 – 12.74 | 10.95 | +14.8% | 265.77B | +4.5% | 17 |
| Next year | 14.06 | 13.15 – 14.90 | 12.56 | +11.9% | 281.85B | +6.1% | 17 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 20, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Oct 16, 2026 | UBS | Maintained | Buy | Buy |
| Aug 19, 2026 | RBC Capital | Initiated | — | Outperform |
| Aug 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 13, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 12, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 12, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 12, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 12, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 12, 2026 | UBS | Maintained | Buy | Buy |
| Aug 12, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 12, 2026 | Baird | Maintained | Outperform | Outperform |
| Jul 24, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 23, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 20, 2026 | UBS | Maintained | Buy | Buy |
| Jul 9, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 2, 2026 | B of A Securities | Maintained | Buy | Buy |
| May 4, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| May 1, 2026 | Citigroup | Maintained | Buy | Buy |
| May 1, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 1, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 28, 2026 | William Blair | Initiated | — | Outperform |
| Apr 8, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Feb 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 10, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 10, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 6, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jan 29, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
